Literature DB >> 12228055

A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats.

F Lugarini1, B J Hrupka, G J Schwartz, C R Plata-Salaman, W Langhans.   

Abstract

Because nonselective cycloooxygenase (COX) inhibition attenuated anorexia after lipopolysaccharide (LPS) administration, we tested the ability of resveratrol (2.5, 10, and 40 mg/kg) and NS-398 (2.5, 10, and 40 mg/kg), selective inhibitors of the two COX isoforms COX-1 and -2, respectively, to attenuate LPS (100 microg/kg ip)-induced anorexia. NS-398 (10 and 40 mg/kg) administered with LPS at lights out attenuated LPS-induced anorexia, whereas resveratrol at all doses tested did not. Because prostaglandin (PG) E(2) is considered the major metabolite synthesized by COX, we measured plasma and cerebrospinal fluid (CSF) PGE(2) levels after LPS administration. LPS induced a time-dependent increase of PGE(2) in CSF but not in plasma. NS-398 (5, 10, and 40 mg/kg) blocked the LPS-induced increase in CSF PGE(2), whereas resveratrol (10 mg/kg) did not. These results support a role of COX-2 in mediating the anorectic response to peripheral LPS and point at PGE(2) as a potential neuromodulator involved in this response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228055     DOI: 10.1152/ajpregu.00200.2002

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  18 in total

Review 1.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

2.  Inflammation-induced lethargy is mediated by suppression of orexin neuron activity.

Authors:  Aaron J Grossberg; XinXia Zhu; Gina M Leinninger; Peter R Levasseur; Theodore P Braun; Martin G Myers; Daniel L Marks
Journal:  J Neurosci       Date:  2011-08-03       Impact factor: 6.167

3.  Direct pyrogenic input from prostaglandin EP3 receptor-expressing preoptic neurons to the dorsomedial hypothalamus.

Authors:  Yoshiko Nakamura; Kazuhiro Nakamura; Kiyoshi Matsumura; Shigeo Kobayashi; Takeshi Kaneko; Shaun F Morrison
Journal:  Eur J Neurosci       Date:  2005-12       Impact factor: 3.386

4.  Cranial dural permeability of inflammatory nociceptive mediators: Potential implications for animal models of migraine.

Authors:  Jun Zhao; Dara Bree; Michael G Harrington; Andrew M Strassman; Dan Levy
Journal:  Cephalalgia       Date:  2016-08-19       Impact factor: 6.292

5.  Lipopolysaccharide differentially decreases plasma acyl and desacyl ghrelin levels in rats: potential role of the circulating ghrelin-acylating enzyme GOAT.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Joseph R Reeve; Yvette Taché; Nils W G Lambrecht
Journal:  Peptides       Date:  2010-06-25       Impact factor: 3.750

6.  Neural controls of prostaglandin 2 pyrogenic, tachycardic, and anorexic actions are anatomically distributed.

Authors:  Karolina P Skibicka; Amber L Alhadeff; Theresa M Leichner; Harvey J Grill
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

Review 7.  Anorexia in human and experimental animal models: physiological aspects related to neuropeptides.

Authors:  Mitsuhiro Yoshimura; Yasuhito Uezono; Yoichi Ueta
Journal:  J Physiol Sci       Date:  2015-06-30       Impact factor: 2.781

8.  Neurobiology of inflammation-associated anorexia.

Authors:  Laurent Gautron; Sophie Layé
Journal:  Front Neurosci       Date:  2010-01-08       Impact factor: 4.677

9.  Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus-brainstem circuit.

Authors:  Clémence Blouet; Young-Hwan Jo; Xiaosong Li; Gary J Schwartz
Journal:  J Neurosci       Date:  2009-07-01       Impact factor: 6.167

10.  Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7.

Authors:  Tomoko Hayashi; Howard B Cottam; Michael Chan; Guangyi Jin; Rommel I Tawatao; Brian Crain; Lisa Ronacher; Karen Messer; Dennis A Carson; Maripat Corr
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-14       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.